Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study

BACKGROUND: Individuals with a family history of colorectal cancer (CRC) are at a high risk of developing CRC. Preclinical studies suggest that the anti-malaria drug proguanil and atovaquone might play a role in preventing CRC, but population-based evidence is still lacking. METHODS: By accessing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Naiqi, Sundquist, Jan, Sundquist, Kristina, Ji, Jianguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650910/
https://www.ncbi.nlm.nih.gov/pubmed/36357883
http://dx.doi.org/10.1186/s12916-022-02643-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650910/
https://www.ncbi.nlm.nih.gov/pubmed/36357883
http://dx.doi.org/10.1186/s12916-022-02643-3

Ejemplares similares